| PERIOD ENDING | 31-May-09 | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 68,816 | 61,837 | 83,597 | 76,916 | | Cost of Revenue | 33,821 | 31,192 | 44,860 | 42,439 | | | Gross Profit | 34,995 | 30,645 | 38,737 | 34,477 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,733 | 22,440 | 26,530 | 25,401 | | Non Recurring |
-
| 2,760 |
-
| 1,340 | | Others | 107 | 110 | 129 | 148 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,155 | 5,335 | 12,078 | 7,588 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (505) | 570 | 479 | 1,831 | | Earnings Before Interest And Taxes | 10,650 | 5,905 | 12,557 | 9,419 | | Interest Expense | 220 | 600 | 698 | 2,052 | | Income Before Tax | 10,430 | 5,305 | 11,859 | 7,367 | | Income Tax Expense | 3,533 | 1,222 | 4,174 | 2,714 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,897 | 4,083 | 7,685 | 4,653 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,897 | 4,083 | 7,685 | 4,653 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,897 | $4,083 | $7,685 | $4,653 |
|
0.33% Nasdaq 
Income Statement
